Heart Inflammation Only Appears After COVID Vaccination: NHS Study
Despite having higher chances of heart inflammation, vaccinated adolescents had significantly lower chances of testing positive for COVID-19 and needing COVID-related hospitalization and critical care compared to their unvaccinated counterparts. Vaccinated children, however, were not substantially different from unvaccinated children in terms of COVID-19 infection and hospitalization.
18 Cases
The study analyzed data from the National Health Service (NHS) England’s OpenSAFELY-TPP database, which covers 40 percent of English primary care practices.Vaccinated adolescents and children were matched to unvaccinated cohorts and followed for 20 weeks to compare positive COVID-19 tests, hospitalizations, COVID-19 critical care, adverse events, and non-COVID hospitalizations.
Adolescents had a higher incidence of post-vaccine myocarditis and pericarditis than children.
There were 15 cases of pericarditis and three cases of myocarditis among more than 839,000 vaccinated children and adolescents. All of the myocarditis and 12 pericarditis cases appeared in the adolescent cohort.
Except for three pericarditis cases, all other cases occurred after the first vaccine dose. More than half of the adolescents with pericarditis and myocarditis were hospitalized or went to the emergency room. It is unknown how many adolescents needed critical care, though the maximum length of stay for myocarditis treatment was one day.
Cardiologist Dr. Peter McCullough, who was not involved in the study, told The Epoch Times that the study is one of many demonstrating that COVID-19 vaccination is not medically necessary for children, given the less than 1 percent rate of infection, and that excessive testing for COVID-19 is a waste of resources.
COVID-19 Hospitalization
The authors also compared myocarditis and COVID-19 hospitalization risks in the vaccinated.While rare, children and adolescents were more likely to be hospitalized with COVID-19 than develop myocarditis or pericarditis, regardless of vaccine status.
Of the adolescents who took one dose of the COVID-19 vaccine, 33 were hospitalized from COVID-19, while three developed myocarditis. In the unvaccinated group, 57 were hospitalized.
Children Are Different
Vaccination appears to significantly reduce the risks of having severe COVID-19 outcomes for adolescents but not for children.Of the over 552,000 unvaccinated children or adolescents, only three cases of COVID-19 required critical care. All three cases occurred among unvaccinated adolescents.
Furthermore, there was no significant difference in COVID-19 infection severity between vaccinated and unvaccinated children.
Other Related Studies
A study out of Massachusetts by Yonker and colleagues explored the significance of vaccine-induced spike protein. The researchers collected blood from 16 adolescent and young adult patients hospitalized with postvaccine myocarditis. They used these blood samples to compare the patients’ immune profiles to those of 45 healthy, age-matched control patients who had also received the vaccine. Three quarters of the myocarditis patients had developed the pathology after the second dose. The researchers did not include a control group of unvaccinated individuals.
Myocarditis Not Recovered in 80 Percent at 6 Months After Vaccination
Barmada et al (2023) studied a clinical cohort consisting of 23 patients hospitalized for vaccine-associated myocarditis and/or pericarditis. The cohort was predominately male (87 percent) with an average age of 16.9 plus/minus 2.2 years (ranging from 13 to 21 years). Patients had largely noncontributory past medical histories and were generally healthy before vaccination. Most patients had symptom onset 1 to 4 days after the second dose of the BNT162b2 mRNA vaccine.
Six patients either first experienced symptoms after a delay of more than seven days after vaccination or were incidentally positive for SARS-CoV-2 by polymerase chain reaction (PCR) testing upon hospital admission—these six patients were thus excluded from further analyses, although they potentially reflect the breadth of clinical presentations of vaccine-associated myopericarditis.
The remaining cohort of 17 patients showed no evidence of recent prior SARS-CoV-2 infection, with antibodies to spike (S) protein but not to nucleocapsid (N) protein and negative nasopharyngeal swab reverse transcription quantitative PCR at hospital admission.While the authors clearly show high levels of inflammatory markers, the follow-up MRI scans showed only 20 percent had resolved their abnormalities (late gadolinium enhancement) at over six months (199 days).
Post-vaccination myocarditis, a form of heart inflammation, was identified in a subset of people who died “unexpectedly” at home within 20 days of receiving a COVID-19 vaccine. Researchers analyzed autopsies that had been performed on the people and conducted additional research, including studying tissue samples.
Researchers started with a group of 35, but excluded 10 from further analysis because other causes of death were identified. Of the remaining 25, researchers identified evidence of myocarditis in five.
All of the five people received a Moderna or Pfizer vaccine within seven days of their death, with a mean of 2.5 days. The median age was 58 years. None of the people had COVID-19 infection prior to being vaccinated and nasal swabs returned negative.
Autopsy findings combined with the lack of evidence of other causes of death and how the vaccination happened shortly before the deaths enabled researchers to say that for three of the cases, vaccination was the “likely cause” of the myocarditis and that the cardiac condition “was the cause of sudden death.”
In one of the other cases, myocarditis was believed to be the cause of death but researchers detected a herpes virus, an alternative explanation for the incidence of heart inflammation. The remaining case did not include an alternative explanation for the myocarditis but the researchers said the impact of the inflammation was “discrete and mainly observed in the pericardial fat.” They classified the two cases as possibly caused by vaccination.
Limitations included the small cohort size.
COVID-19 Vaccine Myocarditis Research Wins 2023 Most Popular Preprints Award
We’re thrilled to announce that Dr Peter McCullough, won first place on Preprints.org for a study he co-authored on vaccine-induced myocarditis.Preprints.org is a vital platform for the early dissemination of scholarly research before standard peer review and publication in scientific journals. By allowing research findings to be shared early with the scientific community, Preprints.org facilitates scientific communication and collaboration, enabling researchers to receive feedback and engage with the broader scientific community.
Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis claimed the top spot in the Medicine and Pharmacology category, specifically focusing on cardiac and cardiovascular systems. This research paper delves into a critical issue surrounding COVID-19 vaccination — the potential risk of myocarditis, particularly in cases where it leads to fatal outcomes.
Treatment protocol for Vaccine induced myocarditis/pericarditis
- ACE inhibitor/ARB, together with carvedilol as tolerated to prevent/limit progressive decline in cardiac function.
- Colchicine in patients with pericarditis – 0.6 mg/day orally; increase to 0.6 mg twice daily if required. Reduce dose if patients develop diarrhea. Monitor white blood cell count. Decrease dose with renal impairment.
- Magnesium to reduce the risk of serious arrhythmias (A starting dose of 100 to 200 mg daily is suggested, increasing the dose as tolerated up to 300 mg (females) to 400 mg daily).
- Coenzyme Q (CoQ) 200-400mg/day. (R, R, R)
- Omega-3 fatty acids – EPA/DHA 2-4 g/day (R). Increase dose slowly as tolerated.
- Resveratrol/flavanoid combination for its anti-inflammatory and antioxidant properties.
- Referral to a cardiologist or ER in case of persistent chest pain or other signs and symptoms of cardiac events are observed.
Resources for Those Injured by the COVID Jab
So, the primary task to prevent and/or address post-jab injuries is to eliminate the spike protein. Ivermectin and hydroxychloroquine bind to and facilitate the removal of spike protein. According to McCullough, nattokinase, bromelain and curcumin also help degrade the spike protein.
The Wellness Company's Base Spike Detox Trio
This base spike protein detox protocol consists of these three powerful ingredients: Spike Support's Nattokinase, Bromelain, and Tumeric Extract.
Vaccinated or not, prioritizing your well-being has never been more crucial.
Buy this ultimate detox bundle today, researched by Dr. Peter McCullough.
Comments
Post a Comment